Federal Register #2026-15799

Tariff Reduction on UK Patented Pharmaceuticals and Ingredients

This notice from the Bureau of Industry and Security (Commerce Department) announces a regulatory change affecting imports of pharmaceuticals from the United Kingdom. - The tariff rate on patented pharmaceuticals and pharmaceutical ingredients from the UK is reduced from 10% to 0%. - Action is taken in accordance with Presidential Proclamation 11020, reflecting a trade agreement between the US and UK. - No specific OEMs, vendors, or product part numbers are identified in the notice. - The change applies broadly to patented pharmaceuticals and pharmaceutical ingredients originating in the UK. - This is a regulatory action, not a procurement or solicitation for products or services.

Description

This notice announces a revision of the tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom. The tariff rate is reduced from 10 percent to zero percent in accordance with Proclamation 11020, which adjusts imports of pharmaceuticals and pharmaceutical ingredients into the United States. The tariff reduction is effective for products entered for consumption or withdrawn from warehouse for consumption on or after July 31, 2026. This action follows the successful conclusion of a pharmaceutical pricing agreement between the United States and the United Kingdom.

View original listing